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Evidence is mounting that epistasis is widespread among mutations. The cost of 8 
carrying two deleterious mutations, or the advantage of acquiring two beneficial 9 
alleles, is typically lower that the sum of their individual effects. Much less is known 10 
on epistasis between beneficial and deleterious mutations, even though this is key to 11 
the amount of genetic hitchhiking that may occur during evolution. This is particularly 12 
important in the context of antibiotic resistance: most resistances are deleterious, but 13 
some can be beneficial and remarkably rifampicin resistance can emerge de novo in 14 
populations evolving without antibiotics. Here we show pervasive positive pairwise 15 
epistasis on Escherichia coli fitness between beneficial mutations, which confer 16 
resistance to rifampicin, and deleterious mutations, which confer resistance to 17 
streptomycin. We find that 65% of double resistant strains outcompete sensitive 18 
bacteria in an environment devoid of antibiotics. Weak beneficial mutations may 19 
therefore overcome strong deleterious mutations and can even render double 20 
mutants strong competitors. 21 
 22 
Introduction 23 
The effect of a mutation may depend on the genetic background where it occurs, a 24 
phenomenon termed epistasis. The existence of pervasive epistasis for mutations 25 
that affect fitness related traits has an important impact on the evolutionary dynamics 26 
of a population and the number of paths accessible to it (Weinreich et al. 2005; 27 
Weinreich et al. 2006; Phillips 2008; de Visser et al. 2011; de Visser and Krug 2014). 28 
Experimental evolution to novel laboratory environments has been used to determine 29 
the importance and type of epistasis underlying evolutionary trajectories (Salverda et 30 
al. 2011; Tenaillon et al. 2012; Kryazhimskiy et al. 2014). Recent studies suggest that 31 
the fitness of the genetic background is a key factor influencing the ability of microbial 32 
populations to adapt or re-adapt (Kahn et al 2011; Sousa et al. 2012; Schenk et al 33 
2013).  34 
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 35 
Both in bacteria and yeast, low fit clonal populations were found to have a higher 36 
capacity to adapt than clonal populations with higher fitness (Kryazhimskiy et al. 37 
2014; Perfeito et al. 2014). Empirical studies have also been performed to directly 38 
measure the strength of epistasis (Ɛ). This was done by measuring both the effect of 39 
single mutations and pairs of mutations combined onto the same genetic background 40 
(de Visser and Krug 2014). Pairs of individually deleterious (Elena and Lenski 1997; 41 
Trindade et al. 2009) or beneficial, at the level of a single gene or between loci (Khan 42 
et al. 2011; Schenk et al. 2013), were studied. Far less is known about epistasis 43 
between beneficial and deleterious mutations, despite its importance to the amount 44 
of genetic hitchhiking on the evolution of asexual populations or genomic regions with 45 
reduced recombination (Johnson and Barton, 2000; Gillespie, 2000) and patterns of 46 
molecular evolution (Kondrashov and Kondrashov, 2015). An important fitness trait 47 
for bacteria is the level of resistance to antibiotics, which can occur in a wide range of 48 
concentrations across environments (Andersson and Hughes 2014). Bacterial 49 
populations show high levels of polymorphism for resistance alleles and epistasis 50 
between resistance alleles is thought to be important in explaining levels of 51 
resistance observed in natural populations (Borrell and Gagneux 2011; Müller et al. 52 
2013) and in determining the evolutionary path towards increased resistance to 53 
certain antibiotics (Weinreich et al. 2006; MacLean et al. 2010; Borrell et al. 2013; de 54 
Visser and Krug 2014). Mutations conferring resistance also exhibit strong Genotype-55 
by-Environment (GxE) interactions. A remarkable example of these types of 56 
interactions occurs in alleles that confer rifampicin and streptomycin resistance. 57 
Strong epistatic interactions of either positive (alleviating) or negative (increasing) 58 
type for the fitness effects of two resistance alleles, were found in different species 59 
and in different environments (Trindade et al. 2009; Ward et al. 2009; MacLean et al. 60 
2010; Trindade et al. 2012). Some resistance alleles can even be beneficial in certain 61 
environments. For example Miskinyte and Gordo (2013) found that streptomycin 62 
(StrR) and also rifampicin (RifR) resistance mutations can benefit E. coli survival 63 
inside macrophages. In this same species several RifR mutations have been also 64 
been found to confer a fitness advantage in minimal glucose medium (Trindade et al. 65 
2012). The spontaneous emergence of RifR alleles has even been reported in E. coli 66 
evolving in poor medium under high temperature (Rodríguez-Verdugo et al. 2013). 67 
Interestingly, in that study the ancestral strain in which rifampicin emerged was 68 
streptomycin resistant. 69 
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Here we study the fitness effects of rifampicin and streptomycin resistance in 70 
poor nutritional medium devoid of antibiotics, where, according to competitive 71 
assays, rifampicin mutations are beneficial and streptomycin resistance incur a 72 
fitness cost (Trindade et al. 2012). We ask three questions: How costly is double 73 
resistance in this environment? How pervasive is epistasis between beneficial and 74 
deleterious alleles? How do the benefits of a single RifR allele vary with the fitness of 75 
the genetic background where it emerges?  76 
 77 
Results and Discussion 78 
In order to determine the effect on fitness of double resistance we performed 79 
competitive fitness assays between the double resistant and a sensitive strain in 80 
minimal media supplemented with glucose. The sensitive strain carries a genetic 81 
marker, which is neutral in this environment (Trindade et al. 2012). Figure 1a shows 82 
the results of the competitive fitness assays. From the 20 double mutants studied 83 
only 3 have a significant fitness cost. We find that 85% of the double resistant strains 84 
have no significant cost and therefore are not expected to be eliminated from the 85 
population when it grows in poor medium. Hitchhiking of deleterious mutants is 86 
observed in the double mutants - K88E+H526N, K43T+H526N, K88R+H526N, 87 
K88R+D516V and K88E+D516N. These represent cases where the deleterious 88 
effect of the StrR mutations is not enough to impair fitness below wild type levels (that 89 
is below 1) and therefore are still expected to outcompete the sensitive strain. Most 90 
importantly, 65% of all clones are actually expected to outcompete the sensitive 91 
strain even in the absence of any antibiotic. This implies that if single resistance 92 
alleles are segregating in populations, double resistance can be a likely end result of 93 
natural selection, in environments where only glucose is present and the selective 94 
pressure of antibiotics is inexistent.  95 
For further understanding the consequences of the resistances, we studied 96 
their ‘trait effects’: growth rate (r) and carrying capacity (K). Each of these traits 97 
contributes to the competitive ability of the resistant clones and have different 98 
relevance when we consider natural populations, which are likely structured (Hall et 99 
al 2014). For example in a metapopulation where extinction and recolonization 100 
occurs, the growth rate and carrying capacity will also be important determinants of 101 
the maintenance of resistance. Figure 1b indicates that only two RifR mutants are 102 
beneficial for r and all show a deleterious effect on their carrying capacity (Fig 1c), 103 
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despite their competitive superiority. It also shows that many doubles resistant clones 104 
have increased growth rates.  105 
  106 
The absence of costs for competitive fitness in the majority of double mutants 107 
could be due to an epistatic interaction between the two. To answer if this was the 108 
case we estimated the level of pairwise epistasis between each pair of mutations. 109 
This is measured as the difference between the observed relative fitness of the 110 
double mutant (Fig. 2a) and the expected fitness, based on the effects of each 111 
individual mutation: Ɛ = WRif.Str-WRif*WStr. Figure 2b shows the estimated values of 112 
epistasis for competitive fitness. We find that positive epistasis is detected between 113 
all pairs of RifR and StrR alleles, which are per se beneficial and deleterious, 114 
respectively, when considered individually. In only a single combination of double 115 
resistance (D516V/K43N) was the level of epistasis not significant, but still resulted in 116 
a positive mean. All other combinations showed a level of Ɛ significantly above 0.  117 
We also studied the pattern of epistasis for the traits r and K of the mutants vs 118 
the sensitive strains. Fig. 2c-f shows that an overall level of positive epistasis is also 119 
observed for both r (mean Ɛ =0.14, 95%CI [0.06,0.21], 60% of the cases with 120 
significant positive epistasis) and K (mean Ɛ =0.20, 95%CI [0.10,0.30], 75% of the 121 
cases with positive epistasis). Hence the costs of double resistance are also smaller 122 
than expected when these genotypes grow independently. 123 
Next we tested for a correlation between the effect of each beneficial 124 
resistance mutation and the fitness of the genetic background where it emerges. 125 
Recently, a negative correlation was found between the amount of fitness increase 126 
and the initial fitness in bacteria and yeast (Perfeito et al. 2014, Kryazhimskiy et al. 127 
2014, Couce and Tenaillon, 2015). Furthermore the effect of specific beneficial 128 
mutations was found to negatively correlate with the fitness of the genetic 129 
background (Kryazhimskiy et al. 2014), although the data supporting a general 130 
pattern is still limited. Figure 3 shows how the beneficial RifR mutations correlate with 131 
the background fitness. We observe a strong significant negative correlation between 132 
the fitness benefit of H526N mutation with the fitness of the genetic background it 133 
arises. For the mutation H526Y, a highly frequent mutation segregating in natural 134 
populations of Mycobacterium tuberculosis (Kapur et al., 1994; Yue et al., 2003; 135 
Gagneux et al., 2006), its fitness benefit correlates marginally with the fitness of the 136 
genetic background. Rodriguez-Verdugo et al. 2013 also found rifampicin alleles 137 
conferring higher fitness improvements in more maladapted genetic backgrounds. In 138 
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the case of mutation D516V it is always beneficial but its effect does not correlate 139 
with the background fitness.  140 
We have previously measured the level of pairwise epistasis for these alleles 141 
in rich medium (LB), an environment where none of these alleles individually was 142 
beneficial (Trindade et al. 2009). We can therefore compare how the level and type 143 
of epistasis changes with the environment and hence evaluate epistasis by 144 
environment interaction (Supplemental Fig 2 and 3). Flynn et al. (2013) have recently 145 
found that the sign and magnitude of epistasis between beneficial mutations in E. coli 146 
can vary with the environment where the cells are grown. For our sample of 147 
resistance alleles we observe a significant genotype by environment interaction for 148 
the level of epistasis, when comparing poor and rich medium. This is observed when 149 
we consider competitive fitness (GxE, P<0.05, ≈9% of the variance) and also the 150 
traits r (GxE, P<0.05, ≈35% of the variance) and K (GxE, P<0.05, ≈55% of the 151 
variance). Although all resistant clones have a smaller fitness, when competing with 152 
the sensitive strains in rich LB medium, some of the mutations confer beneficial 153 
effects at the level of r and K (Supplemental Fig 2 and 3).  154 
Although the sample is small these results, together with those of previous 155 
reports (Remold and Lenski 2004; Lalic and Elena 2012; Zee et al. 2014) suggest 156 
that the type of epistasis may change as the environment changes. Our results also 157 
hint that epistasis between beneficial and deleterious resistance alleles may be more 158 
positive than that between costly resistance alleles. 159 
 160 
Materials and Methods 161 
The strains used were E. coli K12 MG1655 wild-type (ara+) and Δara. Rifampicin-162 
resistant (RifR) and streptomycin-resistant (StrR) clones were the same used in 163 
(Trindade et al. 2009), which we previously showed to exhibit epistasis in rich 164 
medium. Briefly, sets of single spontaneous clones RifR or StrR were obtained by 165 
plating in LB agar medium supplemented with the appropriate antibiotic and 166 
randomly selecting clones after 24h incubation at 37ºC. Single resistant clones were 167 
exposed to a second antibiotic to select for spontaneous mutants resistant to the two 168 
antibiotics. Generalized transduction of the resistance mutations with bacteriophage 169 
P1 was performed to eliminate unknown genetic background effects (Trindade et al., 170 
2009). Four RifR clones were chosen for this study based on their superior fitness in 171 
minimal medium and five StrR clones were chosen based on their inferior fitness in 172 
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minimal medium (Trindade et al. 2012). All 20 pairwise combinations giving rise to 173 
double resistance were tested. The fitness effects of the double resistance mutations 174 
were measured by competitive assays. The double resistant mutants were competed 175 
against a reference strain, E. coli K12 MG1655 Δara, in minimal medium 176 
supplemented with 0.4% of glucose at 37°C, in an approximate proportion of 1:1, for 177 
24 h with aeration. Accurate values of each strain initial and final ratios were 178 
estimated by plating appropriate dilutions of the mixture in Tetrazolium Agar (TA) 179 
agar plates. The fitness effect of each mutant strain—that is, the selection coefficient 180 
(s) —was estimated as the per generation difference in Malthusian parameters for 181 
the resistant strain and the reference strain: s = ln(Rf/Ri)/t,  where t corresponds to 182 
the number of generations and Rf and Ri to the final and initial ratios between 183 
resistant and reference strains, respectively. In minimal medium no cost of the Δara 184 
marker is detected. Five independent assays were done for each double resistant 185 
clone. The competitive fitness values of the double mutants in Luria-Bertani (LB) 186 
medium presented in Supplemental Fig 2 are based on Trindade et al., 2009. The 187 
traits maximum growth rate (r) and carrying capacity (K) were determined at 37ºC 188 
using a 200 µL growth assay in a Bioscreen C Microbiology Reader (Growth Curves 189 
Ltd, Finland), after two days of acclimation to the growth conditions. Growths were 190 
started with 2x106 cells and a minimum of four independent assays were done for 191 
each single and double resistant clone. The OD600nm of cultures in the Bioscreen was 192 
measured every 20 min and the experiments were run for 24 h with continuous 193 
shaking (aeration). In these conditions the growth curves did not display any 194 
evidence of death cell. i.e. a decline in the OD600nm. Maximum growth rate was 195 
calculated as the maximal slope of the exponential phase using four points 196 
corresponding to 1h time interval. Assuming a logistic growth model, the carrying 197 
capacity, or yield, was determined by measuring the final OD600nm after 24h of growth 198 
as commonly used as a proxy for CFUs (MacLean and Buckling, 2009). For LB a 1:4 199 
dilution was done before measuring the OD600nm (Supplemental Fig 1.) 200 
Epistasis (Ɛ) was calculated as in (Trindade et al. 2009), i.e. Ɛ =WRif.Str-WRif*WStr , 201 
where Wi.j is the competitive fitness of the strains, with resistances i and j, against a 202 
sensitive strain carrying a neutral marker. The significance of an epistatic interaction 203 
was determined by error propagation: the error of the value of Ɛ, Ɛ = 204 
√Wab
2σWAB
2 + WAB
2σWab
2 + WaB
2σWAb
2 + WAb
2σWaB
2 , as in previous studies (Trindade 205 
et al. 2009; Silva et al. 2011; Borrell et al. 2013). Whenever the value of ε was within 206 
the error we considered that alleles did not show any significant epistasis. 207 
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Figure Legends 209 
Figure 1. (a) Fitness of each double resistant mutant against a wild-type sensitive 210 
strain measured by competitive fitness assays; and resistance trait effects (b) growth 211 
rates and (c) carrying capacity. K88R, K43N, K88E, K43T and K43R are the StrR 212 
backgrounds where the effect of the RifR alleles D516V, H526N, H526Y and D516N 213 
were measured. All clones with fitness above one are expected to outcompete the 214 
sensitive strain (error bars represent 2SE, n>4). 65% of the mutants with a 215 
combination of the two resistance alleles are beneficial.  216 
 217 
Figure 2. Massive Positive Epistasis between RifR and StrR alleles. (a) Observed 218 
competitive fitness of single and double resistant clones. (b) Maximum growth rates 219 
and (c) carrying capacity. Level of pairwise epistasis at the level of competitive 220 
fitness (b), growth rate (d) and carrying capacity (f). 221 
Figure 3. Effect of genetic background for each beneficial RifR mutation. Diminishing 222 
returns epistasis (Kryazhimskiy et al. 2014) for H526N, i.e. the fitness effect of 223 
H526N significantly decreases with the fitness of the genetic background (i.e. the 224 
cost of streptomycin resistance) (P<0.001, F=309.3). No significant correlation for 225 
alleles D516V, H526N and H526Y is detected. 226 
 227 
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Figure 2
a)
c)
e)
K88E K43N K43T K88R K43R
Sensitive 0.727 0.755 0.78 0.894 0.937
D516V 1.048 1.101 0.803 0.94 1.022 1.093
D516N 1.088 1.066 0.965 0.947 1.124 1.148
H526N 1.094 1.061 1.101 1.065 1.091 1.104
H526Y 1.123 0.994 0.989 1.093 1.213 1.194
>1.18
1.13-1.18
1.08-1.13
1.03-1.08
1.00-1.03
0.970-1.00
0.92-0.97
0.87-0.92
0.82-0.87
0.77-0.82
<0.77
K88E K43N K43T K88R K43R
D516V 0.339 0.011
NS
0.123 0.085 0.111
D516N 0.275 0.144 0.098 0.151 0.129
H526N 0.266 0.275 0.212 0.113 0.079
H526Y 0.178 0.141 0.217 0.209 0.142
>0.28
0.21-0.28
0.14-0.21
0.07-0.14
0-0.07
0.07-0
0.14-0.07
0.21-0.14
0.28-0.21
<0.28
K88E K43N K43T K88R K43R
Sensitive 0.855 0.759 0.890 0.882 1.054
D516V 1.174 1.175 0.851 1.050 1.387 1.181
D516N 0.916 0.811 0.909 1.269 1.064 1.375
H526N 1.102 0.863 0.921 0.954 1.236 1.098
H526Y 0.971 0.972 1.028 1.186 0.926 1.015
K88E K43N K43T K88R K43R
D516V 0.171 -0.040
NS
0.004
NS
0.352 -0.057
NS
D516N 0.028
NS
0.214 0.453 0.256 0.410
H526N -0.079
NS
0.085 -0.027
NS
0.265 -0.063
NS
H526Y 0.142 0.291 0.322 0.070 -0.008
NS
K88E K43N K43T K88R K43R
Sensitive 1.042 0.954 0.848 1.017 0.906
D516V 0.629 0.457 1.046 1.080 0.508 1.000
D516N 0.813 1.016 1.017 0.562 1.088 0.613
H526N 0.650 0.843 0.717 0.723 0.616 0.874
H526Y 0.547 0.924 0.840 0.829 0.626 0.845
b)
K88E K43N K43T K88R K43R
D516V -0.198 0.446 0.546 -0.132 0.430
D516N 0.169 0.240 -0.127 0.261 -0.124
H526N 0.166 0.097 0.172 -0.044 0.285
H526Y 0.354 0.318 0.365 0.070 0.350
d)
f)
+
-
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Figure 3 357 
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Supplemental Data 361 
 362 
Supplemental Figure 1 363 
 364 
Figure S1 – Determination of the linear range of the Bioscreen. Using a 24h 365 
growth overnight in LB we performed a series of 1:2 dilutions to determine the 366 
linear range of the BioScreen. The correlation is lost when OD600nm > 1 and thus, 367 
dilutions were performed to determine the correct carrying capacity of the 368 
strains in LB. In the growths performed in MM, the carrying capacity was always 369 
below 1 and thus, dilutions were not necessary. 370 
 371 
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 373 
Supplemental Figure 2 374 
 375 
Fig S2 – Relative fitness of single and double mutants in LB as measured by (a) 376 
competitive fitness assays, (b) growth rates and (c) carrying capacity. 377 
  378 
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 379 
Fig S3 –Level of pairwise epistasis between RifR and StrR alleles in LB for (a) 380 
competitive fitness, (b) maximum growth rate and (c) for carrying capacity. 381 
 382 
Suplemental Figure 3
a)
c)
e)
>1.18
1.13-1.18
1.08-1.13
1.03-1.08
1.00-1.03
0.970-1.00
0.92-0.97
0.87-0.92
0.82-0.87
0.77-0.82
<0.77
>0.28
0.21-0.28
0.14-0.21
0.07-0.14
0-0.07
0.07-0
0.14-0.07
0.21-0.14
0.28-0.21
<0.28
b)
d)
f)
+
-
K88E K43N K43T K88R K43R
Sensitive 0.761 0.856 0.902 0.975 1.031
D516V 0.976 0.866 0.845 0.893 1.003 0.991
D516N 0.995 0.796 0.718 0.852 0.903 0.996
H526N 1.022 0.777 0.819 0.890 0.977 1.025
H526Y 0.933 0.669 0.906 0.727 0.806 0.913
K88E K43N K43T K88R K43R
D516V 0.085 0.041
NS
0.044 0.087 0.020
D516N 0.068 -0.108 -0.016
NS
-0.036 0.005
NS
H526N 0.027 -0.027 -0.001
NS
0.014 0.004
NS
H526Y -0.016
NS
0.141 -0.089 -0.075 -0.016
NS
K88E K43N K43T K88R K43R
Sensitive 0.702 0.896 0.905 1.030 1.008
D516V 1.015 0.502 0.893 0.952 0.985 1.021
D516N 0.982 0.656 0.822 0.937 0.856 0.952
H526N 0.983 0.618 0.865 0.936 0.930 0.978
H526Y 0.898 0.788 0.723 0.815 0.897 0.889
K88E K43N K43T K88R K43R
Sensitive 0.802 0.785 0.890 0.923 0.893
D516V 0.840 0.875 0.764 0.775 0.816 0.815
D516N 0.873 0.764 0.752 0.813 0.843 0.922
H526N 0.875 0.786 0.757 0.723 0.884 0.848
H526Y 0.809 0.712 0.672 0.769 0.909 0.821
K88E K43N K43T K88R K43R
D516V 0.201 0.105 0.028
NS
0.041
NS
0.065
D516N 0.063 0.066 0.035
NS
0.037
NS
0.142
H526N 0.084 0.069
NS
-0.056
NS
0.077 0.066
H526Y 0.063
NS
0.036
NS
0.049
NS
0.163 0.098
NS
K88E K43N K43T K88R K43R
D516V -0.211 -0.016
NS
0.034
NS
-0.060 -0.002
NS
D516N -0.003 -0.006 0.047 -0.155 -0.038
H526N -0.007 -0.015
NS
0.046 -0.081 -0.012
NS
H526Y 0.157 -0.082
NS
0.002
NS
-0.028 -0.016
NS
